Your Article Summary
See Latest ArticlesDigestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients
Néphrologie & Thérapeutique , 06/09/09
Montagnac R et al. - Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, the authors evoke these complications and illustrate them with some pictures from personal observations.
Related Articles
Association of Dialysis Modality and Cardiovascular Mortality in Incident Dialysis Patients
Clinical Journal of the American Society of Nephrology, 10/06/09
Relevance Score: 91%
Hospitalizations in Patients Treated Sequentially by Chronic Hemodialysis and Continuous Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/21/09
Relevance Score: 90%
Medication Apprehension and Compliance among Dialysis Patients - A Comprehensive Guidance Attitude
Nephron: Clinical Practice, 11/06/09
Relevance Score: 89%
Health-related quality of life in dialysis patients with HCV infection
The International Journal of Artificial Organs, 10/30/09
Relevance Score: 89%
Is Maximum Conservative Management an Equivalent Treatment Option to Dialysis for Elderly Patients with Significant Comorbid Disease
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 89%
Today in Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation
Transplantation Proceedings, 12/18/09
Foxp3 Staining in BK Virus Allograft Nephropathy and Comparison With Acute Cellular Rejection
Transplantation Proceedings, 12/18/09
Statin Therapy Ameliorates Renal Allograft Function
Transplantation Proceedings, 12/18/09